Urea-mediated cross-presentation of soluble epstein-barr virus BZLF1 protein

16Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

Abstract

Soluble extracellular proteins usually do not enter the endogenous human leukocyte antigen (HLA) I-dependent presentation pathway of antigen-presenting cells, strictly impeding their applicability for the re-stimulation of protein-specific CD8+ cytotoxic T lymphocytes (CTL). Here we present for the Epstein-Barr virus (EBV) BZLF1 a novel strategy that facilitates protein translocation into antigen-presenting cells by its solubilisation in high molar urea and subsequent pulsing of cells in presence of low molar urea. Stimulation of PBMC from HLA-matched EBV-seropositive individuals with ureatreated BZLF1 but not untreated BZLF1 induces an efficient reactivation of BZLF1-specific CTL. Urea-treated BZLF1 (uBZLF1) enters antigen-presenting cells in a temperature-dependent manner by clathrin-mediated endocytosis and is processed by the proteasome into peptides that are bound to nascent HLA I molecules. Dendritic cells and monocytes but also B cells can cross-present uBZLF1 in vitro. The strategy described here has potential for use in the development of improved technologies for the monitoring of protein-specific CTL. © 2008 Barabas et al.

Cite

CITATION STYLE

APA

Barabas, S., Gary, R., Bauer, T., Lindner, J., Lindner, P., Weinberger, B., … Deml, L. (2008). Urea-mediated cross-presentation of soluble epstein-barr virus BZLF1 protein. PLoS Pathogens, 4(11). https://doi.org/10.1371/journal.ppat.1000198

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free